| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
25,610 |
23,349 |
$3.51M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
15,913 |
15,456 |
$3.23M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
23,747 |
21,039 |
$3.03M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
439 |
417 |
$1.28M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,679 |
4,006 |
$1.12M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,889 |
8,455 |
$1.06M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,989 |
3,430 |
$978K |
| 80050 |
General health panel |
17,010 |
15,989 |
$737K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12,733 |
7,588 |
$541K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,375 |
4,830 |
$482K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,525 |
5,232 |
$464K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,686 |
3,916 |
$416K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
15,652 |
12,489 |
$406K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,735 |
7,105 |
$346K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,029 |
6,260 |
$318K |
| 80053 |
Comprehensive metabolic panel |
33,985 |
25,598 |
$308K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,083 |
1,064 |
$298K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,286 |
1,041 |
$292K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,057 |
1,755 |
$278K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
42,930 |
29,342 |
$278K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,169 |
2,866 |
$276K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,449 |
2,349 |
$268K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,246 |
11,016 |
$260K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,243 |
4,112 |
$246K |
| G0378 |
Hospital observation service, per hour |
3,097 |
1,674 |
$244K |
| 36415 |
Collection of venous blood by venipuncture |
96,213 |
69,628 |
$238K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,683 |
3,649 |
$215K |
| 87081 |
|
15,102 |
14,077 |
$192K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,291 |
1,252 |
$188K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,797 |
5,062 |
$187K |
| 97597 |
|
3,822 |
1,309 |
$186K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,793 |
5,058 |
$178K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,845 |
3,784 |
$175K |
| 71046 |
Radiologic examination, chest; 2 views |
8,652 |
7,590 |
$170K |
| 80061 |
Lipid panel |
14,477 |
12,515 |
$164K |
| 84484 |
|
9,755 |
5,678 |
$161K |
| 96376 |
|
5,682 |
2,211 |
$159K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,238 |
3,372 |
$156K |
| 87631 |
|
4,732 |
4,270 |
$152K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,290 |
2,715 |
$142K |
| 87581 |
|
1,179 |
1,151 |
$140K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,348 |
718 |
$133K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,040 |
901 |
$130K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,065 |
893 |
$121K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,562 |
6,283 |
$120K |
| 93458 |
|
159 |
42 |
$120K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,822 |
2,009 |
$118K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
257 |
225 |
$112K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,661 |
2,025 |
$112K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,530 |
973 |
$111K |
| 87077 |
|
6,724 |
5,835 |
$111K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
11,123 |
9,563 |
$110K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,921 |
4,686 |
$105K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,892 |
4,355 |
$103K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,108 |
1,807 |
$100K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
829 |
715 |
$100K |
| 71045 |
Radiologic examination, chest; single view |
6,937 |
5,501 |
$97K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,723 |
1,583 |
$91K |
| 93970 |
|
570 |
466 |
$89K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
472 |
410 |
$88K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
8,804 |
7,867 |
$86K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,885 |
1,778 |
$86K |
| 83735 |
|
8,577 |
5,837 |
$84K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,446 |
6,585 |
$84K |
| J2704 |
Injection, propofol, 10 mg |
6,367 |
3,921 |
$84K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,327 |
868 |
$77K |
| 93971 |
|
734 |
652 |
$76K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,151 |
818 |
$75K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
6,686 |
3,759 |
$71K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
710 |
595 |
$69K |
| 71250 |
|
924 |
811 |
$69K |
| 76830 |
Ultrasound, transvaginal |
1,321 |
1,210 |
$69K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,348 |
6,258 |
$68K |
| 81001 |
|
12,460 |
10,406 |
$61K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
145 |
79 |
$52K |
| 87486 |
|
1,179 |
1,151 |
$51K |
| 83690 |
|
6,628 |
5,310 |
$50K |
| 73564 |
|
1,774 |
1,485 |
$48K |
| 83880 |
|
1,829 |
1,481 |
$47K |
| 73630 |
|
2,107 |
1,839 |
$46K |
| 87186 |
|
4,448 |
3,749 |
$44K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
5,707 |
2,704 |
$41K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,460 |
885 |
$41K |
| 84439 |
|
4,323 |
3,741 |
$41K |
| 94664 |
|
1,497 |
1,103 |
$40K |
| C1769 |
Guide wire |
1,115 |
546 |
$39K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
954 |
316 |
$38K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,409 |
2,232 |
$37K |
| 82947 |
|
7,671 |
2,759 |
$36K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,069 |
378 |
$35K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12,179 |
7,817 |
$33K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,832 |
1,913 |
$33K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
634 |
509 |
$32K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
778 |
489 |
$32K |
| 84702 |
|
2,051 |
1,592 |
$32K |
| 82728 |
|
2,569 |
2,293 |
$32K |
| 73610 |
|
1,426 |
1,263 |
$30K |
| 87480 |
|
2,004 |
1,755 |
$30K |
| 87660 |
|
2,004 |
1,755 |
$30K |
| 87510 |
|
2,004 |
1,755 |
$30K |
| 77066 |
Tomosynthesis, mammo |
342 |
287 |
$30K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,368 |
2,922 |
$30K |
| 88142 |
|
1,820 |
1,645 |
$30K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
365 |
319 |
$30K |
| J2785 |
Injection, regadenoson, 0.1 mg |
375 |
252 |
$30K |
| 80306 |
|
1,665 |
1,291 |
$30K |
| 73130 |
|
1,382 |
1,137 |
$28K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
541 |
496 |
$28K |
| 76536 |
|
666 |
611 |
$27K |
| J3490 |
Unclassified drugs |
2,396 |
823 |
$26K |
| 81025 |
|
1,907 |
1,496 |
$26K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
842 |
230 |
$26K |
| 73030 |
|
1,316 |
1,122 |
$26K |
| 97161 |
|
778 |
378 |
$25K |
| 93880 |
|
278 |
233 |
$25K |
| 88342 |
|
1,010 |
786 |
$24K |
| 94760 |
|
4,603 |
2,848 |
$23K |
| 87040 |
|
1,878 |
1,036 |
$23K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,068 |
725 |
$23K |
| 80076 |
|
1,397 |
1,156 |
$22K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,726 |
1,259 |
$22K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,645 |
1,060 |
$22K |
| 84703 |
|
2,722 |
2,273 |
$22K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,057 |
4,109 |
$22K |
| 85610 |
|
4,452 |
2,990 |
$21K |
| 82607 |
|
1,795 |
1,554 |
$20K |
| 72100 |
|
947 |
850 |
$20K |
| 93017 |
|
859 |
553 |
$19K |
| 93041 |
|
1,232 |
927 |
$19K |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,723 |
876 |
$19K |
| 76642 |
|
535 |
484 |
$19K |
| 86140 |
|
3,578 |
2,831 |
$18K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,117 |
946 |
$18K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
884 |
686 |
$18K |
| 88341 |
|
351 |
261 |
$18K |
| 87070 |
|
1,798 |
1,481 |
$18K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
501 |
269 |
$17K |
| 83550 |
|
2,310 |
2,060 |
$17K |
| 83540 |
|
2,624 |
2,342 |
$16K |
| 83605 |
|
1,510 |
1,155 |
$16K |
| 73110 |
|
802 |
686 |
$16K |
| 85380 |
|
1,968 |
1,498 |
$16K |
| 86803 |
|
1,287 |
987 |
$15K |
| 70486 |
|
290 |
241 |
$15K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,063 |
464 |
$15K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
6,687 |
3,724 |
$15K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
241 |
203 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
170 |
140 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,384 |
1,254 |
$13K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
150 |
130 |
$13K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
25 |
24 |
$13K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,999 |
3,316 |
$12K |
| 81003 |
|
3,542 |
3,071 |
$12K |
| 72110 |
|
575 |
518 |
$12K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,913 |
1,649 |
$12K |
| 76801 |
|
107 |
93 |
$12K |
| 86850 |
|
2,227 |
1,293 |
$12K |
| 73502 |
|
675 |
566 |
$11K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
90 |
64 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
382 |
256 |
$11K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
584 |
553 |
$10K |
| 97162 |
|
395 |
296 |
$10K |
| 74018 |
|
786 |
689 |
$10K |
| 82550 |
|
1,616 |
1,233 |
$10K |
| 85730 |
|
1,696 |
1,252 |
$10K |
| 87046 |
|
684 |
344 |
$10K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
32 |
27 |
$10K |
| 82043 |
|
1,653 |
1,515 |
$10K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,821 |
478 |
$9K |
| 93016 |
|
1,132 |
997 |
$9K |
| 87632 |
|
94 |
85 |
$9K |
| 88304 |
|
852 |
453 |
$9K |
| 86780 |
|
1,105 |
838 |
$8K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
697 |
612 |
$8K |
| 86901 |
|
2,602 |
1,587 |
$8K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
290 |
245 |
$8K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
76 |
75 |
$8K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
221 |
180 |
$8K |
| 85027 |
|
2,494 |
2,072 |
$8K |
| 77065 |
Tomosynthesis, mammo |
86 |
77 |
$8K |
| 86900 |
|
2,297 |
1,349 |
$8K |
| 82746 |
|
662 |
570 |
$7K |
| 85652 |
|
2,823 |
2,231 |
$7K |
| 87340 |
|
1,148 |
803 |
$7K |
| 84100 |
|
1,984 |
1,098 |
$7K |
| J2060 |
Injection, lorazepam, 2 mg |
1,551 |
922 |
$7K |
| 99215 |
Prolong outpt/office vis |
253 |
209 |
$7K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
945 |
831 |
$7K |
| 87899 |
|
509 |
344 |
$7K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
30 |
30 |
$6K |
| 93018 |
|
1,137 |
1,001 |
$6K |
| 90715 |
|
282 |
223 |
$6K |
| 77080 |
|
284 |
263 |
$6K |
| 97010 |
|
771 |
201 |
$6K |
| 93922 |
|
124 |
103 |
$6K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
266 |
144 |
$6K |
| 80074 |
|
153 |
138 |
$6K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
185 |
104 |
$6K |
| 73080 |
|
320 |
274 |
$6K |
| 97116 |
|
480 |
109 |
$5K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
628 |
482 |
$5K |
| 96367 |
|
336 |
200 |
$5K |
| 94060 |
|
285 |
245 |
$5K |
| 86618 |
|
690 |
523 |
$5K |
| 86038 |
|
846 |
680 |
$5K |
| 72050 |
|
208 |
191 |
$5K |
| 87481 |
|
76 |
75 |
$5K |
| 70491 |
|
15 |
14 |
$5K |
| 82565 |
|
1,501 |
1,225 |
$5K |
| 87522 |
Neg quan hep c or qual rna |
224 |
192 |
$5K |
| 82784 |
|
631 |
299 |
$4K |
| 87205 |
|
1,370 |
1,040 |
$4K |
| 84146 |
|
200 |
180 |
$4K |
| 72141 |
|
26 |
25 |
$4K |
| 76775 |
|
204 |
172 |
$4K |
| 83021 |
|
243 |
226 |
$4K |
| 82977 |
|
918 |
709 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,117 |
891 |
$4K |
| 76870 |
|
70 |
66 |
$4K |
| 83516 |
|
437 |
252 |
$4K |
| 83020 |
|
243 |
226 |
$4K |
| 83655 |
|
559 |
506 |
$4K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
80 |
79 |
$4K |
| 12001 |
|
88 |
69 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,784 |
894 |
$3K |
| 84460 |
|
908 |
804 |
$3K |
| 84550 |
|
775 |
603 |
$3K |
| 82570 |
|
446 |
352 |
$3K |
| 94729 |
|
228 |
203 |
$3K |
| 84156 |
|
593 |
440 |
$3K |
| 87045 |
|
410 |
344 |
$3K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
314 |
143 |
$3K |
| 83525 |
|
465 |
425 |
$3K |
| 73140 |
|
378 |
306 |
$3K |
| 73590 |
|
150 |
124 |
$3K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
13 |
13 |
$2K |
| 82150 |
|
421 |
359 |
$2K |
| 86235 |
|
74 |
38 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
294 |
236 |
$2K |
| 93321 |
|
69 |
52 |
$2K |
| 83615 |
|
627 |
461 |
$2K |
| 99406 |
|
406 |
141 |
$2K |
| 87015 |
|
569 |
448 |
$2K |
| 84403 |
|
196 |
163 |
$2K |
| 93325 |
|
70 |
51 |
$2K |
| 10060 |
|
31 |
28 |
$2K |
| 84425 |
|
28 |
26 |
$2K |
| 83001 |
|
113 |
96 |
$2K |
| 82950 |
|
515 |
442 |
$2K |
| 72040 |
|
124 |
117 |
$2K |
| 82248 |
|
421 |
359 |
$2K |
| C9399 |
Unclassified drugs or biologicals |
4,743 |
1,427 |
$2K |
| 72070 |
|
138 |
119 |
$2K |
| 96417 |
|
64 |
39 |
$2K |
| C1760 |
Closure device, vascular (implantable/insertable) |
42 |
13 |
$2K |
| C9113 |
Injection, pantoprazole sodium, per vial |
859 |
194 |
$2K |
| 82803 |
|
101 |
79 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
19 |
15 |
$2K |
| 87329 |
|
189 |
163 |
$2K |
| 87449 |
|
176 |
158 |
$2K |
| 86706 |
|
365 |
216 |
$1K |
| J1790 |
Injection, droperidol, up to 5 mg |
246 |
212 |
$1K |
| 86430 |
|
426 |
338 |
$1K |
| 85014 |
|
755 |
445 |
$1K |
| 83002 |
|
61 |
51 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
153 |
105 |
$1K |
| 86762 |
|
323 |
181 |
$1K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
36 |
13 |
$1K |
| 85018 |
|
594 |
394 |
$1K |
| 80069 |
|
135 |
107 |
$1K |
| 87328 |
|
159 |
137 |
$1K |
| 84153 |
|
187 |
177 |
$1K |
| 59025 |
Fetal non-stress test |
56 |
30 |
$1K |
| 86665 |
|
183 |
70 |
$1K |
| 73090 |
|
63 |
55 |
$1K |
| 87324 |
|
157 |
140 |
$1K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
198 |
154 |
$1K |
| 90686 |
|
80 |
41 |
$1K |
| J3480 |
Injection, potassium chloride, per 2 meq |
170 |
69 |
$951.44 |
| 83970 |
|
54 |
42 |
$800.08 |
| 71101 |
|
81 |
77 |
$779.98 |
| 86664 |
|
155 |
70 |
$767.14 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
692 |
474 |
$745.94 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
113 |
61 |
$737.56 |
| 86255 |
|
204 |
150 |
$732.66 |
| 85007 |
|
813 |
567 |
$685.89 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
12 |
$658.72 |
| 83883 |
|
67 |
44 |
$615.19 |
| 90732 |
|
53 |
25 |
$580.38 |
| 73562 |
|
13 |
12 |
$579.24 |
| 82247 |
|
82 |
69 |
$524.74 |
| 84145 |
|
22 |
14 |
$439.96 |
| 86039 |
|
58 |
41 |
$417.58 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
61 |
26 |
$404.78 |
| 87641 |
|
66 |
24 |
$319.61 |
| 86376 |
|
13 |
12 |
$281.33 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
70 |
50 |
$276.98 |
| 74150 |
|
17 |
12 |
$243.88 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
15 |
12 |
$241.93 |
| 12002 |
|
13 |
12 |
$239.73 |
| 0296T |
|
186 |
62 |
$228.48 |
| 84450 |
|
419 |
349 |
$223.68 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
399 |
295 |
$223.14 |
| 84481 |
|
143 |
124 |
$217.37 |
| 93226 |
|
56 |
44 |
$183.23 |
| 84165 |
|
97 |
77 |
$170.87 |
| G0009 |
Administration of pneumococcal vaccine |
53 |
25 |
$160.45 |
| A9270 |
Non-covered item or service |
12,845 |
1,748 |
$159.87 |
| 73522 |
|
16 |
15 |
$156.18 |
| 93225 |
|
58 |
45 |
$129.31 |
| 86481 |
|
15 |
13 |
$125.22 |
| 99152 |
|
28 |
26 |
$121.69 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
426 |
367 |
$119.93 |
| 89055 |
|
15 |
13 |
$117.25 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
34 |
25 |
$91.44 |
| 93923 |
|
31 |
24 |
$88.03 |
| 80164 |
|
12 |
12 |
$59.07 |
| 84402 |
|
44 |
38 |
$58.55 |
| 85347 |
|
147 |
13 |
$53.68 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
59 |
39 |
$51.90 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
67 |
54 |
$47.30 |
| 82272 |
|
57 |
51 |
$38.54 |
| 84155 |
|
65 |
49 |
$37.08 |
| 74022 |
|
26 |
24 |
$30.63 |
| 82105 |
|
30 |
25 |
$28.03 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
187 |
14 |
$27.85 |
| 84436 |
|
99 |
26 |
$22.11 |
| 80178 |
|
17 |
12 |
$17.78 |
| 85045 |
|
14 |
12 |
$10.74 |
| 86308 |
|
14 |
13 |
$8.65 |
| 86003 |
|
15 |
12 |
$7.02 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
483 |
151 |
$3.95 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
78 |
66 |
$0.02 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
692 |
277 |
$0.02 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
673 |
260 |
$0.02 |
| 36430 |
|
22 |
12 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
60 |
41 |
$0.00 |
| 84480 |
|
51 |
39 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
57 |
39 |
$0.00 |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
35 |
25 |
$0.00 |
| 12011 |
|
12 |
12 |
$0.00 |
| 87210 |
|
20 |
13 |
$0.00 |